Epidemiologic analysis of histologic cervical inflammation: relationship to human papillomavirus infections

Human Pathology

Volumn 39, Issue 7, 2008, Pages 1088-1095

  Kovacic, Melinda Butsch ^a   Katki, Hormuzd A ^b   Kreimer, Aimee R ^b   Sherman, Mark E ^b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cervical intraepithelial neoplasia; Epithelium; Histology; Human papillomavirus; Immune infiltrates; Inflammation; Oral contraceptives; Smoking; STDs; Stroma

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER RISK; CANCER SCREENING; CARCINOGENESIS; COLPOSCOPY; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DISSOCIATIVE DISORDER; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SELF REPORT; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVICITIS; UTERINE CERVIX BIOPSY; VIRUS INFECTION; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; FEMALE; HUMANS; MARYLAND; ODDS RATIO; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; RETROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS; UTERINE CERVICITIS;

EID: 45249085940     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.12.002     Document Type: Article

References (32)

1. The ALTS Group. HPV testing as a triage strategy for women with cytologic evidence of low grade squamous intraepithelial lesions: early results from a randomized trial on the clinical management of ASCUS and LSIL cytologic abnormalities. J Natl Cancer Inst 92 (2000) 397-402
2. Gravitt P.E., Peyton C.L., Alessi T.Q., et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 38 (2000) 357-361
3. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. J Natl Cancer Inst 92 (2000) 397-402
4. Schiffman M., Wheeler C.M., Dasgupta A., Solomon D., and Castle P.E. A comparison of a prototype PCR assay and hybrid capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal Papanicolaou smears 2. Am J Clin Pathol 124 (2005) 722-732
5. Castle P.E., Schiffman M., Herrero R., et al. PCR testing of pooled longitudinally collected cervical specimens of women to increase the efficiency of studying human papillomavirus infection 19. Cancer Epidemiol Biomarkers Prev 14 (2005) 256-260
6. Carreón J., Sherman M.E., Guillén D., et al. Poor Reproducibility of CIN2 Compared with CIN3: Attempting to strengthen classification of cervical precancer. Int J Gynecol Pathol 26 (2007) 441-446
7. Diggle P., Liang K., and Zeger S. Analysis of longitudinal data (1994), Oxford University Press, London Pages
8. McCullagh P. Regression models for ordinal data. J R Stat Soc Ser B (Methodological) 42 (1980) 109-142
9. Franklin R.D., and Kutteh W.H. Characterization of immunoglobulins and cytokines in human cervical mucus: influence of exogenous and endogenous hormones. J Reprod Immunol 42 (1999) 93-106
10. Gravitt P.E., Hildesheim A., Herrero R., et al. Correlates of IL-10 and IL-12 concentrations in cervical secretions. J Clin Immunol 23 (2003) 175-183
11. H1 cytokine patterns in cervical human papillomavirus infection. Clin Diagn Lab Immunol 6 (2000) 751-755
12. Barton S.E., Maddox P.H., Jenkins D., Edwards R., Cuzick J., and Singer A. Effect of cigarette smoking on cervical epithelial immunity: a mechanism for neoplastic change. Lancet 2 (1988) 652-654
13. Nadais F.R., Campaner A.B., Piato S., et al. Langerhans' cells and smoking in intraepithelial neoplasia of the cervix. Gynecol Oncol 102 (2006) 356-360
14. Poppe W.A., Ide P.S., Drijkoningen M.P., Lauweryns J.M., Van F., and Assche A. Tobacco smoking impairs the local immunosurveillance in the uterine cervix. An immunohistochemical study. Gynecol Obstet Invest 39 (1995) 34-38
15. Szarewski A., Maddox P., Royston P., et al. The effect of stopping smoking on cervical Langerhans' cells and lymphocytes. BJOG 108 (2001) 295-303
16. Kobayashi A., Greenblatt R.M., Anastos K., et al. Functional attributes of mucosal immunity in cervical intraepithelial neoplasia and effects of HIV infection. Cancer Res 64 (2004) 6766-6774
17. Clerici M., Merola M., Ferrario E., et al. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection. J Natl Cancer Inst 89 (1997) 245-250
18. Kadish A.S., Ho G.Y.F., Burk R., et al. Lymphoproliferative responses to human papillomavirus (HPV) type 16 protein E6 and E7: outcome of HPV infection and associated neoplasia. J Natl Cancer Inst 89 (1997) 1285-1293
19. Kadish A.S., Timmins P., Wang Y., et al. Regression of CIN and loss of HPV infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide. Cancer Epidemiol Biomarkers Prev 11 (2002) 483-488
20. Tsukui T., Hildesheim A., Schiffman M.H., et al. IL-2 production by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology. Cancer Res 56 (1996) 3967-3974
21. H1 cytokine patterns in cervical human papillomavirus infection. Clin Diagn Lab Immunol 6 (1999) 751-755
22. Tjiong M.Y., van der Vange N., ten Kate F.J., et al. Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer. Gynecol Oncol 73 (1999) 285-291
23. Tjiong M.Y., van der Vange N., ter Schegget J.S., Burger M.P., ten Kate F.W., and Out T.A. Cytokines in cervicovaginal washing fluid from patients with cervical neoplasia. Cytokine 14 (2001) 357-360
24. de Gruijl T.D., Bontkes H.J., van den Muysenberg A.J., et al. Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix. Eur J Cancer 35 (1999) 490-497
25. El-Sherif A.M., Seth R., Tighe P.J., and Jenkins D. Quantitative analysis of IL-10 and IFN-gamma mRNA levels in normal cervix and human papillomavirus type 16 associated cervical precancer. J Pathol 195 (2001) 179-185
26. Hazelbag S., Fleuren G.J., Baelde J.J., Schuuring E., Kenter G.G., and Gorter A. Cytokine profile of cervical cancer cells. Gynecol Oncol 83 (2001) 235-243
27. Kobayashi A., Darragh T., Herndier B., et al. Lymphoid follicles are generated in high-grade cervical dysplasia and have differing characteristics depending on HIV status. Am J Pathol 160 (2002) 151-164
28. Mota F., Rayment N., Chong S., Singer A., and Chain B. The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium. Clin Exp Immunol 116 (1999) 33-40
29. Davidson B., Goldberg I., and Kopolovic J. Inflammatory response in cervical intraepithelial neoplasia and squamous cell carcinoma of the uterine cervix. Pathol Res Pract 193 (1997) 491-495
30. Hammes L.S., Tekmal R.R., Naud P., et al. Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression-clinicopathological correlation. Gynecol Oncol 105 (2007) 157-165
31. Castle P.E., Hillier S.L., Rabe L.K., et al. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev 10 (2001) 1021-1027
32. Liaw K.L., Hildesheim A., Burk R.D., et al. A prospective study of HPV type 16 DNA detection by PCR and its association with acquisition and persistence of other HPV types. J Infect Dis 183 (2001) 8-15